Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Foghorn Therapeutics News

Aktie
WKN:  ISIN:  US3441741077 US-Symbol:  FHTX Branche:  Biotechnologie Land:  USA
5,29 $
+0,45 $
+9,30%
4,4968 € 21:58:44 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
8,79%
KGV
-4,70
Index-Zuordnung
-

Foghorn Therapeutics News

14.01.26 - PR Newswire
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire
11.12.25 - PR Newswire
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Platform Technologies Drive $211B Surge in Precision Cancer Treatment PR Newswire
23.10.24 - PR Newswire
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence PR Newswire
03.10.24 - PR Newswire
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors PR Newswire
06.08.24 - PR Newswire
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner PR Newswire
08.02.24 - PR Newswire
Thinking about buying stock in Foghorn Therapeutics, Oscar Health, Eli Lilly And Co, Palo Alto Networks, or CN ENERGY GROUP?
Thinking about buying stock in Foghorn Therapeutics, Oscar Health, Eli Lilly And Co, Palo Alto Networks, or CN ENERGY GROUP? PR Newswire
27.11.23 - PR Newswire
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders PR Newswire
21.11.23 - PR Newswire
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics PR Newswire
01.11.23 - PR Newswire
Flagship Pioneering Launches Pioneering Intelligence
Flagship Pioneering Launches Pioneering Intelligence PR Newswire
11.09.23 - PR Newswire
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire
29.08.23 - PR Newswire
Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
Invaio achieves first registration for citrus greening solution featuring Trecise™ technology PR Newswire
16.05.23 - PR Newswire
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry PR Newswire
10.05.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire
02.05.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire
26.04.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire
28.02.22 - PR Newswire
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire
15.02.22 - PR Newswire
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT PR Newswire
13.12.21 - PR Newswire
Thinking about buying stock in Arena Pharmaceuticals, Bellus Health, Foghorn Therapeutics, Hexo Corp, or bluebird bio?
Thinking about buying stock in Arena Pharmaceuticals, Bellus Health, Foghorn Therapeutics, Hexo Corp, or bluebird bio? PR Newswire
13.12.21 - PR Newswire
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform Establishes co-​development and co-...
25.05.21 - PR Newswire
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture PR Newswire

Newssuche

Videos

newspaper
16.04.26 +1,90%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »